Goodwin Advises Ardan Equity on its Acquisition of Clinical ink
October 29, 2026
October 29, 2026
BOSTON, Massachusetts, Oct. 29 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:
* * *
Goodwin Advises Ardan Equity on its Acquisition of Clinical ink
*
The Technology M&A and Private Equity teams advised Ardan Equity ("Ardan") on its acquisition of Clinical ink, a global clinical trial technology company, through its flagship Ardan Equity Fund I and affiliated funds.
With Goodwin as . . .
* * *
Goodwin Advises Ardan Equity on its Acquisition of Clinical ink
*
The Technology M&A and Private Equity teams advised Ardan Equity ("Ardan") on its acquisition of Clinical ink, a global clinical trial technology company, through its flagship Ardan Equity Fund I and affiliated funds.
With Goodwin as . . .